These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30776158)

  • 1. A proliferation-inducing ligand increase precedes IgA nephropathy recurrence in kidney transplant recipients.
    Martín-Penagos L; Benito-Hernández A; San Segundo D; Sango C; Azueta A; Gómez-Román J; Fernández-Fresnedo G; López-Hoyos M; Ruiz JC; Rodrigo E
    Clin Transplant; 2019 Apr; 33(4):e13502. PubMed ID: 30776158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of tumor necrosis factor superfamily 13 with recurrence of immunoglobulin A nephropathy in living related kidney transplantation.
    Jo HA; Han SS; Lee S; Kim JY; Yang SH; Lee H; Yang JS; Lee JP; Joo KW; Lim CS; Kim YS; Ahn C; Han JS; Kim DK
    BMC Nephrol; 2019 Jan; 20(1):33. PubMed ID: 30704417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation.
    Garnier AS; Duveau A; Demiselle J; Croué A; Subra JF; Sayegh J; Augusto JF
    PLoS One; 2018; 13(4):e0196101. PubMed ID: 29694420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents.
    Avasare RS; Rosenstiel PE; Zaky ZS; Tsapepas DS; Appel GB; Markowitz GS; Bomback AS; Canetta PA
    Am J Nephrol; 2017; 45(2):99-106. PubMed ID: 28056461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
    Takahara M; Nagato T; Nozaki Y; Kumai T; Katada A; Hayashi T; Harabuchi Y
    Cell Immunol; 2019 Jul; 341():103925. PubMed ID: 31088610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profile of BAFF in peripheral blood from patients of IgA nephropathy: Correlation with clinical features and Streptococcus pyogenes infection.
    Zheng N; Fan J; Wang B; Wang D; Feng P; Yang Q; Yu X
    Mol Med Rep; 2017 Apr; 15(4):1925-1935. PubMed ID: 28260100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-Cell Activating Factor Predicts Acute Rejection Risk in Kidney Transplant Recipients: A 6-Month Follow-Up Study.
    Wang XZ; Wan Z; Xue WJ; Zheng J; Li Y; Ding CG
    Front Immunol; 2019; 10():1046. PubMed ID: 31156628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients.
    Pongpirul W; Chancharoenthana W; Pongpirul K; Leelahavanichkul A; Kittikowit W; Jutivorakool K; Nonthasoot B; Avihingsanon Y; Eiam-Ong S; Praditpornsilpa K; Townamchai N
    Nephrology (Carlton); 2018 Feb; 23(2):169-174. PubMed ID: 27888573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression.
    Von Visger JR; Gunay Y; Andreoni KA; Bhatt UY; Nori US; Pesavento TE; Elkhammas EA; Winters HA; Nadasdy T; Singh N
    Clin Transplant; 2014 Aug; 28(8):845-54. PubMed ID: 24869763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation.
    Berthoux F; Suzuki H; Mohey H; Maillard N; Mariat C; Novak J; Julian BA
    J Am Soc Nephrol; 2017 Jun; 28(6):1943-1950. PubMed ID: 28255003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent IgA nephropathy after renal transplantation and steroid withdrawal.
    Di Vico MC; Messina M; Fop F; Barreca A; Segoloni GP; Biancone L
    Clin Transplant; 2018 Apr; 32(4):e13207. PubMed ID: 29345747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.
    Moroni G; Longhi S; Quaglini S; Gallelli B; Banfi G; Montagnino G; Messa P
    Nephrol Dial Transplant; 2013 May; 28(5):1305-14. PubMed ID: 23229925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy.
    Han SS; Huh W; Park SK; Ahn C; Han JS; Kim S; Kim YS
    Transpl Int; 2010 Feb; 23(2):169-75. PubMed ID: 19761553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-center long-term results of renal transplantation for IgA nephropathy.
    Bumgardner GL; Amend WC; Ascher NL; Vincenti FG
    Transplantation; 1998 Apr; 65(8):1053-60. PubMed ID: 9583865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical importance of the updated Oxford classification in allograft IgA nephropathy.
    Park S; Go H; Baek CH; Kim YH; Kim YC; Yang SH; Lee JP; Min SI; Ha J; Song EY; Kim YS; Park SK; Lee H; Moon KC
    Am J Transplant; 2019 Oct; 19(10):2855-2864. PubMed ID: 31017369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.
    Leeaphorn N; Garg N; Khankin EV; Cardarelli F; Pavlakis M
    Transpl Int; 2018 Feb; 31(2):175-186. PubMed ID: 28926143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy.
    Temurhan S; Akgul SU; Caliskan Y; Artan AS; Kekik C; Yazici H; Demir E; Caliskan B; Turkmen A; Oguz FS; Sever MS
    Transplant Proc; 2017 Apr; 49(3):541-545. PubMed ID: 28340830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Clinical Outcomes of First and Second Kidney Transplantation in Patients With Biopsy-Proven IgA Nephropathy.
    Kim Y; Yeo SM; Kang SS; Park WY; Jin K; Park SB; Park UJ; Kim HT; Han S
    Transplant Proc; 2017 Jun; 49(5):992-996. PubMed ID: 28583574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
    Namba Y; Oka K; Moriyama T; Ichimaru N; Kyo M; Kokado Y; Ito T; Imai E; Aozasa K; Okuyama A; Takahara S
    Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.